Literature DB >> 3606686

Monoclonal murine anti-DNA antibody interacts with living mononuclear cells.

K Okudaira, H Yoshizawa, R C Williams.   

Abstract

A monoclonal mouse antibody, 4-B-5, that reacted with both single-stranded DNA (ssDNA) and double-stranded DNA showed direct reactivity and cell association with mouse thymocytes, as well as peripheral blood mononuclear cells. Absorption of 4-B-5 with peripheral blood mononuclear cells or with mouse thymocytes markedly reduced reactivity with both ssDNA and double-stranded DNA. However, treatment of mouse thymocytes or human T cells with DNase completely eliminated monoclonal anti-DNA reactivity with cells. The cellular reactivity was completely restored when monoclonal anti-DNA was incubated with DNase-treated cells in the presence of normal human serum. Normal human serum was found to contain 574 +/- 639 ng/ml of ssDNA. Coincubation or cell preincubation of mouse thymocytes with ssDNA produced a marked increase in 4-B-5 cell association. These findings indicate that mouse monoclonal anti-DNA can react with and can penetrate both mouse and human mononuclear cells, and that this reactivity may depend on the presence of cell membrane DNA on both types of target cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3606686     DOI: 10.1002/art.1780300610

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

1.  The predestination of autoantibodies.

Authors:  D Alarcón-Segovia
Journal:  Curr Rheumatol Rep       Date:  2001-06       Impact factor: 4.592

2.  Evidence of autoantibodies to cell membrane associated DNA (cultured lymphocytes): a new specific marker for rapid identification of systemic lupus erythematosus.

Authors:  G Servais; M P Guillaume; N Dumarey; J Duchateau
Journal:  Ann Rheum Dis       Date:  1998-10       Impact factor: 19.103

3.  Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1.

Authors:  K Yanase; R M Smith; A Puccetti; L Jarett; M P Madaio
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

4.  Molecular and structural analysis of nuclear localizing anti-DNA lupus antibodies.

Authors:  M H Foster; T Kieber-Emmons; M Ohliger; M P Madaio
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

5.  Effect of antibodies to double stranded DNA, purified from serum samples of patients with active systemic lupus erythematosus, on the glomerular mesangial cells.

Authors:  C Y Tsai; T H Wu; K H Sun; C L Yu
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

6.  Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-1beta, IL-6, IL-8, IL-10 and TNF-alpha from normal human mononuclear cells involving in the lupus pathogenesis.

Authors:  K H Sun; C L Yu; S J Tang; G H Sun
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

Review 7.  B cells and autoantibodies in the pathogenesis of lupus nephritis.

Authors:  M P Madaio
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

8.  H9724, a monoclonal antibody to Borrelia burgdorferi's flagellin, binds to heat shock protein 60 (HSP60) within live neuroblastoma cells: a potential role for HSP60 in peptide hormone signaling and in an autoimmune pathogenesis of the neuropathy of Lyme disease.

Authors:  L H Sigal; S Williams; B Soltys; R Gupta
Journal:  Cell Mol Neurobiol       Date:  2001-10       Impact factor: 5.046

9.  Antibody penetration of viable human cells. I. Increased penetration of human lymphocytes by anti-RNP IgG.

Authors:  J Ma; G V Chapman; S L Chen; G Melick; R Penny; S N Breit
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

10.  DNA-histone complexes as ligands amplify cell penetration and nuclear targeting of anti-DNA antibodies via energy-independent mechanisms.

Authors:  Markella Zannikou; Sofia Bellou; Petros Eliades; Aikaterini Hatzioannou; Michael D Mantzaris; George Carayanniotis; Stratis Avrameas; Peggy Lymberi
Journal:  Immunology       Date:  2015-11-24       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.